Healthcare provider profile · identity verified

Naimah D. Powell, M.D.

Emergency Medicine · LAKE ELSINORE, CA · NPI 1720057623

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	336	103
Amlodipine Besylate	Amlodipine Besylate	277	85
Levothyroxine Sodium	Levothyroxine Sodium	277	75
Lisinopril	Lisinopril	239	70
Losartan Potassium	Losartan Potassium	205	61
Vitamin D2	Ergocalciferol (Vitamin D2)	177	66
Hydrochlorothiazide	Hydrochlorothiazide	168	56
Metformin Hcl	Metformin Hcl	166	55
Metoprolol Succinate	Metoprolol Succinate	142	39
Rosuvastatin Calcium	Rosuvastatin Calcium	131	41
Pantoprazole Sodium	Pantoprazole Sodium	123	43
Ibuprofen	Ibuprofen	121	34
Albuterol Sulfate Hfa	Albuterol Sulfate	120	42
Zolpidem Tartrate	Zolpidem Tartrate	114	13
Tramadol Hcl	Tramadol Hcl	103	23
Gabapentin	Gabapentin	100	35
Eliquis	Apixaban	97	25
Omeprazole	Omeprazole	90	32
Trazodone Hcl	Trazodone Hcl	83	23
Famotidine	Famotidine	75	29
Alprazolam	Alprazolam	73	24
Allopurinol	Allopurinol	72	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	23
Carvedilol	Carvedilol	69	25
Celecoxib	Celecoxib	68	26
Benazepril Hcl	Benazepril Hcl	67	17
Ezetimibe	Ezetimibe	66	23
Metoprolol Tartrate	Metoprolol Tartrate	63	23
Valsartan	Valsartan	63	22
Clonazepam	Clonazepam	61	suppressed
Sertraline Hcl	Sertraline Hcl	59	21
Furosemide	Furosemide	56	21
Atenolol	Atenolol	53	16
Clopidogrel	Clopidogrel Bisulfate	53	20
Oxybutynin Chloride Er	Oxybutynin Chloride	53	16
Ozempic	Semaglutide	53	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	18
Ibandronate Sodium	Ibandronate Sodium	51	14
Simvastatin	Simvastatin	49	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	49	11
Triamcinolone Acetonide	Triamcinolone Acetonide	49	20
Escitalopram Oxalate	Escitalopram Oxalate	48	14
Fluticasone Propionate	Fluticasone Propionate	48	20
Lorazepam	Lorazepam	46	suppressed
Lovastatin	Lovastatin	45	13
Alendronate Sodium	Alendronate Sodium	42	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Potassium Chloride	Potassium Chloride	41	14
Tamsulosin Hcl	Tamsulosin Hcl	41	15
Temazepam	Temazepam	41	suppressed
Hydralazine Hcl	Hydralazine Hcl	39	15
Meloxicam	Meloxicam	39	13
Myrbetriq	Mirabegron	39	suppressed
Jardiance	Empagliflozin	38	suppressed
Januvia	Sitagliptin Phosphate	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	13
Farxiga	Dapagliflozin Propanediol	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	13
Glipizide Er	Glipizide	32	suppressed
Risedronate Sodium	Risedronate Sodium	32	14
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Acyclovir	Acyclovir	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	16
Meclizine Hcl	Meclizine Hcl	30	11
Spironolactone	Spironolactone	30	suppressed
Baclofen	Baclofen	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Azithromycin	Azithromycin	28	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	27	suppressed
Cephalexin	Cephalexin	26	19
Finasteride	Finasteride	26	suppressed
Glimepiride	Glimepiride	26	suppressed
Prednisone	Prednisone	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Estradiol	Estradiol	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	20
Carisoprodol	Carisoprodol	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	23	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	21	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Glipizide	Glipizide	20	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Clotrimazole	Clotrimazole	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Linzess	Linaclotide	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Lubiprostone	Lubiprostone	17	suppressed
Nystatin	Nystatin	17	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Cilostazol	Cilostazol	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Adapalene-Benzoyl Peroxide	Adapalene/Benzoyl Peroxide	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Ciclopirox	Ciclopirox	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Tretinoin	Tretinoin	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	11
Etodolac	Etodolac	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error